Tenderwize
Back to tender search

Medicinal product with active combination Formoterol, Glycopyrroniumbromide and Beclometason (ATC R03AL09)

AOK Sachsen - Anhalt·Magdeburg, Germany·Deadline Mar 30, 2028 · 591 days left·Open·Supplies
Structured notice only
Original notice title

Germany – Pharmaceutical products – Arzneimittel mit der Wirkstoffkombination Wirkstoffkombination Formoterol, Glycopyrroniumbromid und Beclometason (ATC-Code: R03AL09)

50/100

Opportunity Score

Needs reviewLow complexity
SuppliesOpen
Why this score?

Opportunity

50 / 100

Complexity

20 / 100

Risk factors

Contracts may be terminated early if AOK Sachsen-Anhalt decides to tender exclusive contracts for the same active ingre...

The notice explicitly states it is not a public procurement under GWB/EU directives, so legal remedies under procuremen...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration 2 YEAR
  • Non-exclusive discount agreements for finished medicinal products with active combination Formoterol, Glycopyrroniumbromide and Beclometason (ATC R03AL09)
  • Open-house model: any eligible pharmaceutical company can conclude a contract at any time under uniform conditions
Show full summary

Non-exclusive discount agreement (open-house model) for pharmaceutical products with active combination Formoterol, Glycopyrroniumbromide and Beclometason (ATC R03AL09) by AOK Sachsen-Anhalt. The procedure is explicitly not a public procurement under GWB, published for transparency. Any eligible pharmaceutical company can join at any time under uniform conditions. Contract duration up to 24 months, earliest start 01.06.2026, end 31.05.2028. No estimated value or award criteria provided.

Risks

Contracts may be terminated early if AOK Sachsen-Anhalt decides to tender exclusive contracts for the same active ingre...

The notice explicitly states it is not a public procurement under GWB/EU directives, so legal remedies under procuremen...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Administrative

  • Interested pharmaceutical companies must request participation documents and the contract from the contact address
  • Participation requires fully completed and signed participation documents
  • Submission of documents via postal mail or electronically with qualified electronic signature (eIDAS) to [email protected]

Requirements may be incomplete.

Buyer

Location

Magdeburg, DEU

Buyer profile

Open profile

Identifier

DE258393558

Activity

Health

Lots (1)

LOT-0001

Medicinal product with active combination Formoterol, Glycopyrroniumbromide and Beclometason (ATC R03AL09)

Non-exclusive discount agreement under §130a(8) SGB V for the specified active combination, open-house model with anytime accession. No exclusivity, no individual negotiations. Contract ends 31.05.2028 regardless of start date; may be terminated earlier if exclusive contracts are tendered.

SuppliesEU fundedElectronic submission

Location

DEE03, Germany

Duration

2 YEAR

Category

Pharmaceutical products

Deadline

Deadline Mar 30, 2028

Procurement Details

Publication date
20 Apr 2026
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
272002-2026

Documents (1)

Similar tenders